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Thymic carcinoid is a rare cancer and is categorized asone of the families of thymic carcinoma.1-3 Manyparaneoplastic syndromes were reported concomitantwith thymic carcinoid, including Cushing syndrome,
acromegaly, endocrine abnormalities,2,3 and so on. Myasthenia
gravis is one of the concomitant paraneoplastic syndromes with
thymic neoplasm. Its association with thymic carcinoma, how-
ever, has previously only been reported for the cell type of
well-differentiated squamous cell carcinoma.4,5 Here we report
the case of a patient with thymic carcinoid who underwent en
bloc resection of the locally advanced tumor and in whom
myasthenia gravis was diagnosed with acute respiratory failure
31 days after surgery.
Clinical Summary
A 47-year-old female patient was quite well before an anterior
mediastinal mass was found during routine checkup. After thoracic
computed tomographic examination (Figure 1), fine-needle aspi-
ration was performed in a local hospital, but without a definitive
diagnosis. The patient was then referred to our hospital for further
management. During her first admission, physical examination
revealed no abnormal neurologic signs. Because of an impression
of thymic tumor with local organ invasion, the patient underwent
en bloc resection of tumors, including complete thymectomy,
tumor excision, partial pericardiectomy, wedge resection of the
upper lobe of the left lung, and local mediastinal lymph node
dissection. Grossly, two pieces of tumor mass measuring 8  6 
4 cm and 2  1.5  1 cm were noted. Pathologic reports revealed
that it was a thymic carcinoid with cellular atypia (Figure 2). The
lung parenchyma was spared, but the subpleural connective tissue
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Figure 1. CT scans. A, 2  1.5  1 cm nodule over right thymus.
B, 8  6  4 cm mass with direct invasion of pericardium and
dense adhesion to upper lobe of left lung.
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and pericardium were invaded. The lymph nodes were free from
metastasis. Results of immunohistochemical staining of tumors
were positive for synaptophysin, focally positive for neuron-
specific enolase, and negative for chromatogranin.
The patient was discharged uneventfully 1 week after the
operation. Twenty-four days after discharge, while waiting for
radiotherapy, she had dyspnea, orthopnea, dysphagia, and dyspho-
nia. She was sent to the emergency service. Results of edropho-
nium chloride (Tensilon) and repetitive stimulation tests were
positive for a diagnosis of myasthenia gravis. Pulmonary function
tests revealed a severe restrictive ventilatory defect. Respiratory
failure developed, and the patient underwent endotracheal intuba-
tion 2 days after admission, although pyridostigmine was given.
Plasma exchange failed because of complicated anaphylactic
shock. As an alternative, the patient received intravenous immu-
noglobulin for 5 days (doses totaling 120 g). She was successfully
weaned from the ventilator and extubated 13 days later. Postop-
erative radiotherapy was then given (total dose 5040 cGy). The
patient has been followed up for more than 1 year in the outpatient
clinic and is still receiving prednisolone treatment without symp-
toms or tumor recurrence.
Discussion
Of the 42 patients with thymic carcinoma in our institution from
July 1988 to September 2002, 3 had a diagnosis of carcinoid, with
2 of them having no associated paraneoplastic syndrome. Consis-
tent with reports in the literature,4 our previous data indicated that
thymic carcinoma with myasthenia gravis only occurred with the
cell type of well-differentiated squamous cell carcinoma,5 and the
symptoms of myasthenia gravis were always seen before thymic
carcinoma was diagnosed.
To our knowledge, thymic carcinoid combined with myasthe-
nia gravis has not been reported before. When a patient with
thymic carcinoid demonstrates muscle weakness, no matter
whether it develops before or after surgery, myasthenia gravis
should be included in the differential diagnosis.
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Figure 2. Tumor was composed of polygonal cells with finely granular nuclei and moderate eosinophilic
cytoplasm. Tumor cells were arranged in solid nests, festoons, and rosettelike pattern. (Hematoxylin and eosin,
original magnification 40.)
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